NCT01709474 Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus Status TERMINATED Phase PHASE2
NCT01689350 A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment Status COMPLETED Phase NA
NCT01689025 An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase PHASE1
NCT01687309 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender Status COMPLETED Phase PHASE1
NCT01687192 Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. Status COMPLETED Phase PHASE2
NCT01649765 Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy Status COMPLETED Phase PHASE2
NCT01642706 Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments Status UNKNOWN Phase N/A
NCT01632241 Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE4
NCT01616472 WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) Status COMPLETED Phase N/A
NCT01597622 BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 Status COMPLETED Phase PHASE3
NCT01597492 A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE4
NCT01559090 Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. Status COMPLETED Phase PHASE2
NCT01549184 Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia Status COMPLETED Phase N/A
NCT01541670 Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis Status TERMINATED Phase PHASE1
NCT01534403 Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects Status COMPLETED Phase PHASE2
NCT01520155 CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE) Status COMPLETED Phase N/A